Related Experiment Video

Updated: Jun 5, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Chemoprevention of hepatocellular carcinoma by acyclic retinoid

Masahito Shimizu1, Hiroyasu Sakai, Hisataka Moriwaki

  • 1Department of Medicine, Gifu University Graduate School of Medicine, Gifu, Japan. shimim-gif@umin.ac.jp

Frontiers in Bioscience (Landmark Edition)
|January 4, 2011
PubMed

Insights

Hepatocellular carcinoma (HCC) prevention is crucial. Acyclic retinoid (ACR) shows promise by inhibiting key pathways involved in liver cancer development, improving patient survival and offering a new chemoprevention strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) has a poor prognosis, necessitating effective prevention strategies.
  • Retinoids and their receptors play a critical role in HCC development, with malfunctions linked to liver carcinogenesis.
  • RXRalpha malfunction, driven by Ras-MAPK pathway phosphorylation, is a key factor in liver cancer.

Purpose of the Study:

  • To review the role of retinoids in HCC development.
  • To explore the potential of targeting Ras-MAPK signaling and RXRalpha phosphorylation for HCC chemoprevention.
  • To evaluate the efficacy of acyclic retinoid (ACR) in preventing liver carcinogenesis.

Main Methods:

  • Review of existing literature on retinoid signaling in HCC.
  • Analysis of the mechanism of action of acyclic retinoid (ACR) on Ras-MAPK and RXRalpha.
  • Examination of clinical trial data for ACR in HCC prevention.

Main Results:

  • Acyclic retinoid (ACR) inhibits Ras-MAPK activation and RXRalpha phosphorylation, suppressing HCC cell growth.
  • ACR has demonstrated improved patient survival in clinical trials, particularly in preventing viral HCC.
  • ACR functions as a key drug in combination chemoprevention strategies.

Conclusions:

  • Acyclic retinoid (ACR) is a promising agent for HCC chemoprevention.
  • Targeting Ras-MAPK signaling and RXRalpha phosphorylation offers a viable therapeutic approach.
  • "Clonal deletion" therapy using ACR is a practical strategy for preventing liver carcinogenesis.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...